Terms: = Head and neck cancer AND HSP90AB1, HSPCB, 3326, ENSG00000096384, HSP90B, HSP90-BETA, P08238, D6S182, HSPC2, FLJ26984 AND Treatment
3 results:
1. Role of deubiquitinase JOSD2 in the pathogenesis of esophageal squamous cell carcinoma.
Wang WP; Shi D; Yun D; Hu J; Wang JF; Liu J; Yang YP; Li MR; Wang JF; Kong DL
World J Gastroenterol; 2024 Feb; 30(6):565-578. PubMed ID: 38463028
[TBL] [Abstract] [Full Text] [Related]
2. hsp90b enhances MAST1-mediated cisplatin resistance by protecting MAST1 from proteosomal degradation.
Pan C; Chun J; Li D; Boese AC; Li J; Kang J; Umano A; Jiang Y; Song L; Magliocca KR; Chen ZG; Saba NF; Shin DM; Owonikoko TK; Lonial S; Jin L; Kang S
J Clin Invest; 2019 Oct; 129(10):4110-4123. PubMed ID: 31449053
[TBL] [Abstract] [Full Text] [Related]
3. Secondary head and neck cancer in patients with history of hematological malignancy.
Chung JC; Tsang RK; To VS; Ho AC; Chan JY; Ho WK; Wei WI
Head Neck; 2013 May; 35(5):729-32. PubMed ID: 22585675
[TBL] [Abstract] [Full Text] [Related]